| |
| |
|
| Insider
Information: |
Hyde Joseph R III |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,411,298 |
|
|
Indirect Shares
|
2,672,247 |
|
|
| Direct
Value |
$245,254,219 |
|
|
|
Indirect Value
|
$6,749,827 |
|
|
| Total
Shares |
7,083,545 |
|
|
| Total
Value |
$252,004,046 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-10-01 |
4 |
A |
$12.80 |
$9,000 |
D/D |
703 |
7,709,180 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-07-01 |
4 |
A |
$3.05 |
$9,000 |
D/D |
2,951 |
5,581,023 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-10-01 |
4 |
A |
$3.44 |
$9,000 |
D/D |
2,616 |
5,583,640 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-04-01 |
4 |
A |
$2.57 |
$9,000 |
D/D |
3,502 |
9,734,882 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-04-01 |
4 |
A |
$3.35 |
$9,750 |
D/D |
2,910 |
6,678,072 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2011-01-01 |
4 |
A |
$2.65 |
$9,750 |
D/D |
3,679 |
9,731,380 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-17 |
4 |
B |
$3.74 |
$10,452 |
I/I |
2,794 |
845,109 |
2.17 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-01-01 |
4 |
A |
$4.20 |
$10,500 |
D/D |
2,500 |
6,375,162 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-04-01 |
4 |
A |
$4.04 |
$13,625 |
D/D |
3,373 |
9,405,014 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-07-01 |
4 |
A |
$6.62 |
$13,625 |
D/D |
2,058 |
9,590,371 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-10-01 |
4 |
A |
$1.87 |
$13,625 |
D/D |
7,286 |
10,723,785 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-01-02 |
4 |
A |
$1.68 |
$13,625 |
D/D |
8,110 |
11,577,156 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-04-01 |
4 |
A |
$1.56 |
$13,625 |
D/D |
8,734 |
18,205,739 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2014-07-01 |
4 |
A |
$1.39 |
$13,625 |
D/D |
9,802 |
18,215,542 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-12-05 |
4 |
B |
$13.90 |
$13,761 |
D/D |
990 |
7,113,488 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2007-12-05 |
4 |
S |
$13.90 |
$13,761 |
I/I |
(990) |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-01-03 |
4 |
A |
$5.21 |
$15,625 |
D/D |
2,999 |
4,322,099 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-04-03 |
4 |
A |
$4.90 |
$15,625 |
D/D |
3,189 |
2,075,287 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2017-10-02 |
4 |
A |
$7.94 |
$15,625 |
D/D |
1,968 |
3,983,530 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-01-02 |
4 |
A |
$11.46 |
$15,625 |
D/D |
1,363 |
1,734,893 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-04-02 |
4 |
A |
$17.47 |
$15,625 |
D/D |
894 |
1,927,773 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-07-02 |
4 |
A |
$15.47 |
$15,625 |
D/D |
1,010 |
1,928,783 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-10-01 |
4 |
A |
$1.50 |
$15,625 |
D/D |
10,417 |
1,939,199 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2019-01-02 |
4 |
A |
$0.86 |
$15,625 |
D/D |
18,169 |
4,207,368 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2013-01-01 |
4 |
A |
$4.20 |
$16,375 |
D/D |
3,899 |
9,132,861 |
0 |
- |
|
178 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
